Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1909 1
1911 1
1925 1
1936 1
1939 1
1944 2
1945 2
1946 5
1947 3
1948 5
1949 7
1950 3
1951 10
1952 5
1953 8
1954 8
1955 8
1956 7
1957 11
1958 11
1959 8
1960 10
1961 15
1962 14
1963 14
1964 9
1965 14
1966 14
1967 10
1968 15
1969 19
1970 18
1971 22
1972 12
1973 32
1974 23
1975 21
1976 25
1977 19
1978 45
1979 48
1980 47
1981 31
1982 42
1983 26
1984 45
1985 42
1986 34
1987 44
1988 55
1989 34
1990 49
1991 49
1992 62
1993 61
1994 54
1995 59
1996 65
1997 64
1998 45
1999 47
2000 55
2001 72
2002 68
2003 46
2004 51
2005 51
2006 84
2007 72
2008 91
2009 84
2010 89
2011 89
2012 85
2013 90
2014 79
2015 82
2016 67
2017 111
2018 107
2019 116
2020 106
2021 135
2022 83
Text availability
Article attribute
Article type
Publication date

Search Results

3,167 results
Results by year
Filters applied: . Clear all
Page 1
Bimekizumab versus Secukinumab in Plaque Psoriasis.
Reich K, Warren RB, Lebwohl M, Gooderham M, Strober B, Langley RG, Paul C, De Cuyper D, Vanvoorden V, Madden C, Cioffi C, Peterson L, Blauvelt A. Reich K, et al. Among authors: warren rb. N Engl J Med. 2021 Jul 8;385(2):142-152. doi: 10.1056/NEJMoa2102383. Epub 2021 Apr 23. N Engl J Med. 2021. PMID: 33891380 Clinical Trial.
Bimekizumab versus Adalimumab in Plaque Psoriasis.
Warren RB, Blauvelt A, Bagel J, Papp KA, Yamauchi P, Armstrong A, Langley RG, Vanvoorden V, De Cuyper D, Cioffi C, Peterson L, Cross N, Reich K. Warren RB, et al. N Engl J Med. 2021 Jul 8;385(2):130-141. doi: 10.1056/NEJMoa2102388. Epub 2021 Apr 23. N Engl J Med. 2021. PMID: 33891379 Clinical Trial.
Transmission of drug-resistant tuberculosis in HIV-endemic settings.
Khan PY, Yates TA, Osman M, Warren RM, van der Heijden Y, Padayatchi N, Nardell EA, Moore D, Mathema B, Gandhi N, Eldholm V, Dheda K, Hesseling AC, Mizrahi V, Rustomjee R, Pym A. Khan PY, et al. Among authors: warren rm. Lancet Infect Dis. 2019 Mar;19(3):e77-e88. doi: 10.1016/S1473-3099(18)30537-1. Epub 2018 Dec 13. Lancet Infect Dis. 2019. PMID: 30554996 Free PMC article. Review.
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.
Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, Farhat MR, Guthrie JL, Laukens K, Miotto P, Ofori-Anyinam B, Dreyer V, Supply P, Suresh A, Utpatel C, van Soolingen D, Zhou Y, Ashton PM, Brites D, Cabibbe AM, de Jong BC, de Vos M, Menardo F, Gagneux S, Gao Q, Heupink TH, Liu Q, Loiseau C, Rigouts L, Rodwell TC, Tagliani E, Walker TM, Warren RM, Zhao Y, Zignol M, Schito M, Gardy J, Cirillo DM, Niemann S, Comas I, Van Rie A. Meehan CJ, et al. Among authors: warren rm. Nat Rev Microbiol. 2019 Sep;17(9):533-545. doi: 10.1038/s41579-019-0214-5. Nat Rev Microbiol. 2019. PMID: 31209399 Review.
The oral microbiota in colorectal cancer is distinctive and predictive.
Flemer B, Warren RD, Barrett MP, Cisek K, Das A, Jeffery IB, Hurley E, O'Riordain M, Shanahan F, O'Toole PW. Flemer B, et al. Among authors: warren rd. Gut. 2018 Aug;67(8):1454-1463. doi: 10.1136/gutjnl-2017-314814. Epub 2017 Oct 7. Gut. 2018. PMID: 28988196 Free PMC article.
Ixekizumab for the treatment of psoriasis: up-to-date.
Craig S, Warren RB. Craig S, et al. Among authors: warren rb. Expert Opin Biol Ther. 2020 Jun;20(6):549-557. doi: 10.1080/14712598.2020.1729736. Epub 2020 Mar 10. Expert Opin Biol Ther. 2020. PMID: 32050819 Review.
Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F. Twelves S, et al. Among authors: warren rb. J Allergy Clin Immunol. 2019 Mar;143(3):1021-1026. doi: 10.1016/j.jaci.2018.06.038. Epub 2018 Jul 21. J Allergy Clin Immunol. 2019. PMID: 30036598 Free PMC article.
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial.
Reich K, Papp KA, Blauvelt A, Langley RG, Armstrong A, Warren RB, Gordon KB, Merola JF, Okubo Y, Madden C, Wang M, Cioffi C, Vanvoorden V, Lebwohl M. Reich K, et al. Among authors: warren rb. Lancet. 2021 Feb 6;397(10273):487-498. doi: 10.1016/S0140-6736(21)00125-2. Lancet. 2021. PMID: 33549193 Clinical Trial.
3,167 results